Lakewood-Amedex Biotherapeutics announces annual shareholder meeting

• Lakewood-Amedex Biotherapeutics will hold its annual shareholder meeting virtually on Sept. 22, 2026.
• Shareholders will vote to elect four directors for one-year terms.
• Ballots include a charter amendment to raise authorized common shares to 100,000,000 from 12,500,000.
• Investors will also vote on board authority for reverse stock splits up to a cumulative 1-for-20, plus a larger 2020 equity plan share pool.
• The meeting will also cover ratification of CBIZ CPAs as independent auditor for fiscal 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lakewood-Amedex Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-087336), on August 10, 2026, and is solely responsible for the information contained therein.